跳至主要内容
临床试验/NCT07725601
NCT07725601招募中不适用

VNS Algorithm for Advanced Dosing: Example Guided Mode Titrations "The Augusta Way"

Fernando Vale1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2025年8月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
80
试验地点
1
主要终点
Seizure Diary

研究概览

简要总结

The goal of this clinical trial is to compare the standard programming of the VNS device (Control) to a modified programming (Augusta Way) in adults with epilepsy. The main question it aims to answer is:

Does the modified programming of the VNS reduce seizures faster than the standard programming?

Participants in both groups will:

  1. Attend up to 3 study visits every 3 months for 2 years
  2. Answer questionnaires to assess quality of life and cognitive function
  3. Maintain a diary of seizure activity

详细描述

Little has changed in the last 10 years or more in regard to Vagus nerve stimulator (VNS) therapy programming parameters despite new technological advances. The goal of our study is to provide a comprehensive VNS dosing protocol which VNS programmers can refer to as the standard care of treatment escalation in patients with drug refectory epilepsy. Given the lack of newly published data regarding VNS system parameters, this study will allow epileptologists, general neurologists and neurosurgeons alike, access to an updated reference and model of VNS parameter escalation and treatment.

The investigators at Augusta University have developed a programming paradigm that appears to provide good clinical outcomes for VNS patients. The study will provide a comprehensive assessment of an experimental group ("the Augusta Way") programmed with a modified, more rapid titration paradigm developed at our site vs. "best clinical practice" (standard titration paradigm) control group of patients with VNS devices. The patients will be followed for at least 24 months post implantation. The study will assess safety of the new programming paradigm and will assess efficacy based upon seizure outcomes.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects who are clinically determined to be candidates for VNS implantation for seizure control
  • Subject/legally authorized representative able to provide informed consent.

排除标准

  • Subjects with VNS system treating pathologies other than drug refractory epilepsy or medical co-morbidities that prevent any surgical intervention

结局指标

主要结局

Seizure Diary

时间窗: From enrollment to end of participation at 2 years

A seizure diary is a personalized log used to record seizure activity, medication adherence, and potential triggers

次要结局

未报告次要终点

研究者

发起方
Fernando Vale
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Fernando Vale

Allen Distinguished Chair in Neurosurgery

Augusta University

研究点 (1)

Loading locations...

相似试验